Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Samuel Brodovsky has maintained a Hold rating on OrthoPediatrics (NASDAQ:KIDS) and increased the price target from $35 to $38.

May 08, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Hold rating on OrthoPediatrics but raises the price target from $35 to $38.
The increase in price target by Truist Securities suggests a positive outlook on OrthoPediatrics' stock value in the short term, potentially leading to increased investor interest and a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90